Identity
- Security key
- 15450
- Ticker
- FLNA
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2000-07-14
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- FLNA
Detail
Enriched 2026-08-14 20:47
- Market cap
- $45,085,759.34
- Shares outstanding (class)
- 48,307,896
- Shares outstanding (weighted)
- 48,307,896
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 20
- Location
- AUSTIN, TX
- Homepage
- https://www.filanatx.com
- Description
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.